5-Alpha Reductase Inhibition Provides Superior Benefits to Alpha Blockade by Preventing AUR and BPH-Related Surgery
- 31 May 2004
- journal article
- research article
- Published by Elsevier
- Vol. 45 (5) , 620-627
- https://doi.org/10.1016/j.eururo.2003.09.012
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Long-Term Risk Of Re-Treatment Of Patients Using α-Blockers For Lower Urinary Tract SymptomsJournal of Urology, 2002
- SERUM PROSTATE SPECIFIC ANTIGEN IS A STRONG PREDICTOR OF FUTURE PROSTATE GROWTH IN MEN WITH BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 2000
- Prostate Volume and Serum Prostate–Specific Antigen as Predictors of Acute Urinary RetentionEuropean Urology, 2000
- Urinary Retention in Patients with BPH Treated with Finasteride or Placebo over 4 YearsEuropean Urology, 2000
- The management of men with acute urinary retentionBritish Journal of Urology, 1998
- Transurethral resection of the prostateamong medicare beneficiaries in the United States: time trends and outcomesUrology, 1994
- The quality of information recorded on a UK database of primary care records: A study of hospitalizations due to hypoglycemia and other conditionsPharmacoepidemiology and Drug Safety, 1994
- The Effect of Finasteride in Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1992
- Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasiaJournal of Clinical Endocrinology & Metabolism, 1992
- Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.BMJ, 1991